AMGN TEZSPIRE® reports positive Phase 3 results in eosinophilic esophagitis
AMGN says its TEZSPIRE® showed positive Phase 3 results across the co-primary and all key secondary endpoints in eosinophilic esophagitis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.